Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Primary Ciliary Dyskinesia Panel Mayo Clinic Laboratories Mayo Clinic United States | 4 | 39 |
|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
CFAP300 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 99 | 101 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Primary Ciliary Dyskinesia (PCD) via the CFAP300 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Invitae Neonatal Respiratory Distress Panel Invitae United States | 163 | 111 |
|
Heterotaxy, Situs Inversus and Kartagener's Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 43 | 48 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 162 | 129 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 44 | 50 |
|
PreventionGenetics, part of Exact Sciences United States | 135 | 133 |
|
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome and Cystic Fibrosis Panel PreventionGenetics, part of Exact Sciences United States | 44 | 51 |
|
Primary Immunodeficiency Panel Baylor Genetics United States | 1 | 463 |
|
CGC Genetics Unilabs Portugal | 1 | 107 |
|
CGC Genetics Unilabs Portugal | 1 | 178 |
|
Immunodeficiencies and Immunologic Diseases Panel (Complete) Mendelics Brazil | 1 | 397 |
|
Primary Ciliary Dyskinesia Panel Mendelics Brazil | 1 | 35 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
CFAP300 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.